Cystic Fibrosis (CF) Clinical Trials in Birmingham, Alabama

5 studies are recruiting for cystic fibrosis (cf) in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Ensuring Access to Optimal Therapy in CF: The ENACT Study

   This clinical trial is examining the action and effects of several new drugs in the treatment of cystic fibrosis in children. In addition, several genetic factors are examined. The hope is that the ability to determine prior to treatment those individuals who will or will not respond to existing th…

   Stage

   Phase 4

   Ages

   3 and older

   Site

   The University of Alabama at Birmingham, Birmingham, Alabama

   Locations

   3 in total

   Run by

   Arkansas Children's Hospital Research Institute

   See if you can join NCT07148739 on ClinicalTrials.gov

2. Kidney Function in People With Cystic Fibrosis in the Era of HEMT

   The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with…

   Stage

   Not phased

   Ages

   7 and older

   Site

   University of Alabama at Birmingham, Birmingham, Alabama

   Locations

   3 in total

   Run by

   University of Virginia

   See if you can join NCT06595420 on ClinicalTrials.gov

3. Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

   This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.

   Stage

   Not phased

   Ages

   12 and older

   Site

   University of Alabama at Birmingham, Birmingham, Alabama

   Locations

   18 in total

   Run by

   Jaeb Center for Health Research

   See if you can join NCT06837181 on ClinicalTrials.gov

4. OnTrackCF: Engagement, Feasibility, and Acceptability Study

   This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Alabama-Birmingham, Birmingham, Alabama

   Locations

   3 in total

   Run by

   Boston Children's Hospital

   See if you can join NCT07031323 on ClinicalTrials.gov

5. Study With Phage for CF Subjects With Pseudomonas Lung Infection

   The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Alabama at Birmingham, Birmingham, Alabama

   Locations

   14 in total

   Run by

   BiomX Ltd

   See if you can join NCT06998043 on ClinicalTrials.gov